LGALS1 and cranioectodermal dysplasia: Since several immunoregulatory mechanisms are dysregulated in mucosal tissue of CeD patients (108) and Gal-1 displays broad tolerogenic and anti-inflammatory activities in mucosal tissues (29), we evaluated the expression of this lectin in biopsies of CeD patients with or without gluten withdrawal (Table 1).